Silencing Antibiotic Resistance with Antisense Oligonucleotides
Antisense technologies consist of the utilization of oligonucleotides or oligonucleotide analogs to interfere with undesirable biological processes, commonly through inhibition of expression of selected genes. This field holds a lot of promise for the treatment of a very diverse group of diseases in...
Main Authors: | Saumya Jani, Maria Soledad Ramirez, Marcelo E. Tolmasky |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/4/416 |
Similar Items
-
Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides
by: Damian Kaniowski, et al.
Published: (2022-10-01) -
Identification of the Acinetobacter baumannii Ribonuclease P Catalytic Subunit: Cleavage of a Target mRNA in the Presence of an External Guide Sequence
by: Carol Davies-Sala, et al.
Published: (2018-10-01) -
Effective Antiviral Application of Antisense in Plants by Exploiting Accessible Sites in the Target RNA
by: Cornelia Gruber, et al.
Published: (2023-12-01) -
<italic toggle="yes">Tombusvirus</italic> p19 Captures RNase III-Cleaved Double-Stranded RNAs Formed by Overlapping Sense and Antisense Transcripts in <named-content content-type="genus-species">Escherichia coli</named-content>
by: Linfeng Huang, et al.
Published: (2020-06-01) -
A New Antisense Phosphoryl Guanidine Oligo-2′-O-Methylribonucleotide Penetrates Into Intracellular Mycobacteria and Suppresses Target Gene Expression
by: Yulia V. Skvortsova, et al.
Published: (2019-09-01)